Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Considering the mechanistic overlap in the development and progression of CKD in type 1 and type 2 diabetes, there exists a strong rationale for simultaneously developing novel CKD therapies for use in both type 1 diabetes and type 2 diabetes and studying the repurposing of existing type 2 diabetes CKD therapies for the treatment of CKD in people with type 1 diabetes
Public health nutrition
mLST8 Promotes mTOR-Mediated Tumor Progression
Through innovative research, scientists have been testing the use of GSH in Parkinsons disease
US$ 22.16
.webp)
US$ 23.64
US$ 24.39
US$ 28.19
